Welke plaats heeft FOLFOXIRI + bevacizumab bij de behandeling van gemetastaseerd colorectaal carcinoom?
Marinde J. G. Bond(Utrecht University), K. Punt, Miriam Koopman(Utrecht University), Guus M. Bol(Johns Hopkins University)
Cited by 0
Related Papers
Genome-wide cell-free DNA fragmentation in patients with cancer
|Nature|2019|1.5k
Deficient mismatch repair system in patients with sporadic advanced colorectal cancer
|British Journal of Cancer|2009|518
DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis
|The Lancet Oncology|2018|419
ESMO Guidance for Reporting Oncology real-World evidence (GROW)
|Annals of Oncology|2023|209